Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharma has made its name with treatment for cystic fibrosis, but has big plans in cell and genetic therapies – and has just chalked up fast-track status from the FDA for a cell-based ...
See reviews below to learn more or submit your own review. How do I know I can trust these reviews about The Standard Insurance Company? How do I know I can trust these reviews about The Standard ...
After hours: March 26 at 7:34:24 PM EDT Loading Chart for VRTX ...
Standard Capital Markets Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 91.69 Crore) operating in Financial Services sector. Standard Capital Markets Ltd. key ...
Acer Aspire VX-15 is a Windows 10 Home laptop with a 15.60-inch display that has a resolution of 1920x1080 pixels. It is powered by a Core i7 processor and it comes with 8GB of RAM. The Acer Aspire VX ...
A strategic deal with Bain Capital Asia, which will invest Rs 4,385 crore through a preferential allotment at Rs 236 per share, at a premium of 30%, will give it an 18% stake in the company ...
Nifty Midcap 100 set to outrun Nifty 50 for fifth straight financial year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results